Global Sodium Iodide Injection Market Growth 2023-2029

Global Sodium Iodide Injection Market Growth 2023-2029

The global Sodium Iodide Injection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Sodium Iodide Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Sodium Iodide Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Sodium Iodide Injection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Sodium Iodide Injection players cover Curium Pharma, BWXT Medical Ltd., PDRadiopharma Inc., Nova-Tech,Inc., APP Pharmaceuticals,LLC, China Resources Zizhu Pharmaceutical Co., Ltd. and Shanghai Atomic Kexing Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Sodium Iodide Injection Industry Forecast” looks at past sales and reviews total world Sodium Iodide Injection sales in 2022, providing a comprehensive analysis by region and market sector of projected Sodium Iodide Injection sales for 2023 through 2029. With Sodium Iodide Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sodium Iodide Injection industry.

This Insight Report provides a comprehensive analysis of the global Sodium Iodide Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sodium Iodide Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sodium Iodide Injection market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sodium Iodide Injection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sodium Iodide Injection.

This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Iodide Injection market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Sodium Iodide I-131 Injection
Sodium Iodide I-123 Injection

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Curium Pharma
BWXT Medical Ltd.
PDRadiopharma Inc.
Nova-Tech,Inc.
APP Pharmaceuticals,LLC
China Resources Zizhu Pharmaceutical Co., Ltd.
Shanghai Atomic Kexing Pharmaceutical Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sodium Iodide Injection market?

What factors are driving Sodium Iodide Injection market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sodium Iodide Injection market opportunities vary by end market size?

How does Sodium Iodide Injection break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.